Inst Diagnosti (Chile) Today
Inst Diagnosti is trading at 1590.60 as of the 17th of December 2024, a 0.28 percent decrease since the beginning of the trading day. The stock's open price was 1595.0. The performance scores are derived for the period starting the 17th of November 2024 and ending today, the 17th of December 2024. Click here to learn more.
Valuation
Check how we calculate scores
Inst Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Inst Diagnosti's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Inst Diagnosti or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Care, Healthcare (View all Sectors) |
Inst Diagnosti (INDISA) is traded on Chilean Stock Exchange in Chile and employs 2,979 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 216 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inst Diagnosti's market, we take the total number of its shares issued and multiply it by Inst Diagnosti's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Inst Diagnosti operates under Healthcare sector and is part of Medical Care industry. The entity has 140.93 M outstanding shares.
Inst Diagnosti has accumulated about 18.3 B in cash with 14.83 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 129.85.
Check Inst Diagnosti Probability Of Bankruptcy
Inst Stock Against Markets
Inst Diagnosti Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inst Diagnosti stock to make a market-neutral strategy. Peer analysis of Inst Diagnosti could also be used in its relative valuation, which is a method of valuing Inst Diagnosti by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Inst Diagnosti Corporate Management
Elected by the shareholders, the Inst Diagnosti's board of directors comprises two types of representatives: Inst Diagnosti inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inst. The board's role is to monitor Inst Diagnosti's management team and ensure that shareholders' interests are well served. Inst Diagnosti's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inst Diagnosti's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julio Barriga | Operations Mang | Profile | |
| Alejandro Palaneck | Admin Mang | Profile | |
| Cecilia Ojeda | HR Mang | Profile | |
| Manuel Cambiaso | G Mang | Profile |
Other Information on Investing in Inst Stock
Inst Diagnosti financial ratios help investors to determine whether Inst Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inst with respect to the benefits of owning Inst Diagnosti security.